DSM-5 News

 
 
  • ASCPHospitalization Rates Drop With LAIs in Schizophrenia Switching patients with schizophrenia from oral antipsychotics to a long-acting injectable antipsychotic can result in a significant drop in rates of hospitalization for psychotic episodes.
  • ASAMNovel Nonopioid Approach Promising for Opioid Dependence The combination of a muscle relaxant, an antihistamine, and an anticonvulsant may be a better way to detox opioid-dependent patients than a protocol that involves buprenorphine/naltrexone.
  • Preschool Depression Strong Predictor of Later MDD Preschoolers with depressive syndrome run a significantly increased risk for major depression later in childhood.
  • Positive Topline Results for New Schizophrenia Drug Once-monthly treatment with aripiprazole lauroxil, a new injectable, long-acting antipsychotic, significantly reduces positive and negative symptoms in schizophrenia patients.
  • ADAAHoarding Severity Mirrors Level of Family Accommodation The extent to which family members accommodate and tolerate an individual's hoarding behavior is linked to severity of the disorder.
  • Excessive Tanning an Addiction? Underlying psychiatric stress, including anxiety and substance abuse, may explain why some individuals tan excessively even after experiencing serious negative consequences, such as skin cancer.
  • DSM-5: Autism Prevalence May Drop DSM-5 criteria for autism spectrum disorder may lower prevalence estimates, with potential implications for care.
  • Potential New Risk Factors for Tourette's, Tics Identified Inadequate maternal weight gain, cannabis use during pregnancy, and birth order have been identified as 3 new potential risk factors for Tourette syndrome and tic disorders in children.
  • DSM-5 Typo: Pedophilia Described as 'Sexual Orientation' The APA has announced there is an error in the DSM-5 in which pedophilic disorder is mistakenly described using the term 'sexual orientation' instead of 'sexual interest.'
  • APADSM-5 Officially Launched, but Controversy Persists After almost a decade of development and more than 2 years of frequently searing controversy, the DSM-5 has been officially released.
  • Use DSM-5 'Cautiously, If at All,' DSM-IV Chair Advises In a new commentary, DSM-IV chair Allen Frances is highly critical of newly released DSM-5 and advises physicians use it "cautiously, if at all."
  • APADSM-5 Release Likely to Steal the Spotlight at APA Meeting Although there are a myriad of clinical topics up for discussion at this year's annual meeting, it's unlikely that any will garner as much attention as release of the DSM-5.
  • DSM-5 Criteria for BD May Further Cloud Diagnosis The Lancet puts the spotlight on bipolar disorder in a series that details the latest in diagnosis and treatment of the disorder, as well as the added confusion that is likely to ensue with DSM-5.
  • NIMH, APA Clash Over Upcoming DSM-5 The NIMH has released a statement sharply criticizing the upcoming DSM-5 and reports that the organization "will be re-orienting its research away from DSM categories."
  • DSM-5 Somatic Symptom Disorder Debate Rages On Inclusion of the new diagnosis of somatic symptom disorder in the upcoming DSM-5 continues to spark debate, with former DSM-IV chair Allen Frances urging clinicians to ignore the category completely.
  • No Impact of DSM-5 Criteria on Alcohol Disorder Prevalence Although criteria used to assess alcohol problems will change in the upcoming DSM-5, a new study suggests that these changes will not affect the prevalence of the disorder.
  • APA Answers Criticism of Pharma-Influenced Bias in DSM-5 The American Psychiatric Association has released a statement reiterating strict rules that they adhered to in order to ensure that the DSM-5 remained free from industry-influenced bias.
  • Experts React to DSM-5 Approval Reactions to the APA's rubber stamping of the DSM-5 range from 'cautious optimism' to 'a sad day for psychiatry.'
  • DSM-5 Gets APA's Official Stamp of Approval The final diagnostic criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders has been approved by the American Psychiatric Association's leadership.
  • Published DSM-5 Field Trial Results Prompt Renewed Criticism Publication of the final results of the field trials for the upcoming DSM-5 has prompted renewed criticism from one of its most vocal critics.